The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Melatonin protects against 6‐OHDA‐induced neurotoxicity in rats: a role for mitochondrial complex I activity
Abstract
Unilateral injection into the right substantia nigra of the catecholaminergic neurotoxin 6‐hydroxydopamine (6‐OHDA) produces extensive loss of dopaminergic cells (‘hemi‐parkinsonian rat’). The pineal hormone melatonin, which is a potent antioxidant against different reactive oxygen species and has been reported to be neuroprotective in vivo and in vitro , was evaluated for potential anti‐Parkinson effects in this model. Imbalance in dopaminergic innervation between the striata produced by intranigral administration of 6‐OHDAresults in a postural asymmetry causing rotation away from the nonlesioned side. Melatonin given systemically prevented apomorphine‐induced circling behavior in 6‐OHDA‐lesioned rats. Reduced activity of mitochondrial oxidative phosphorylation enzymes has been suggested in some neurodegenerative diseases; in particular, selective decrease in complex I activity is observed in the substantia nigra of Parkinson's disease patients. Analysis of mitochondrial oxidative phosphorylation enzyme activities in nigral tissue from 6‐OHDA‐lesioned rats by a novel BN‐PAGE histochemical procedure revealed a clear loss of complex I activity, which was protected against in melatonintreated animals. A good correlation between behavioral parameters and enzymatic (complex I) analysis was observed independent of melatonin administration. A deficit in mitochondrial complex I could conceivably contribute to cell death in parkinsonism via free radical mechanisms, both directly via reactive oxygen species production and by decreased ATP synthesis and energy failure. Melatonin may have potential utility in the treatment of neurodegenerative disorders where oxidative stress is a participant.—Dabbeni‐Sala, F., Di Santo, S., Franceschini, D., Skaper, S. D., Giusti, P. Melatonin protects against 6‐OHDA‐induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J. 15, 164–170 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation
Monteiro, H. P., & Winterbourn, C. C. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90512-1 · Cited by 125
Perumal, A. S., Gopal, V. B., Tordzro, W. K., Cooper, T. B., & Cadet, J. L. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90142-k · Cited by 120
Cited by
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Melatonin mitigates mitochondrial malfunction
León, J., Acuña‐Castroviejo, D., Escames, G., Tan, D., & Reiter, R. J. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00181.x · Cited by 514
Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster
Coulom, H., & Birman, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2993-04.2004 · Cited by 421
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K.-H., & Chen, C.-M. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 341
Melatonin and mitochondrial function
Leon, J., Acuña-Castroviejo, D., Sainz, R. M., Mayo, J. C., Tan, D.-X., & Reiter, R. J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.03.003 · Cited by 332
Metadata
- Authors
- DABBENI-SALA, F., DI Santo, S., FRANCESCHINI, D., D. SKAPER, S., & PIETRO GIUSTI, A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 15
- Issue
- 1
- Pages
- 164-170
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2153024208
- Cited by
- 192
- References
- 4
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.